228 related articles for article (PubMed ID: 10608500)
1. Hypereosinophilia.
Bain BJ
Curr Opin Hematol; 2000 Jan; 7(1):21-5. PubMed ID: 10608500
[TBL] [Abstract][Full Text] [Related]
2. World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management.
Gotlib J
Am J Hematol; 2014 Mar; 89(3):325-37. PubMed ID: 24577808
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndrome.
Wang SA; Hasserjian RP; Tam W; Tsai AG; Geyer JT; George TI; Foucar K; Rogers HJ; Hsi ED; Rea BA; Bagg A; Bueso-Ramos CE; Arber DA; Verstovsek S; Orazi A
Haematologica; 2017 Aug; 102(8):1352-1360. PubMed ID: 28495918
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in pathogenesis and management of hypereosinophilic syndromes.
Roufosse F; Cogan E; Goldman M
Allergy; 2004 Jul; 59(7):673-89. PubMed ID: 15180753
[TBL] [Abstract][Full Text] [Related]
5. Clonal eosinophilic disorders and the hypereosinophilic syndrome.
Brito-Babapulle F
Blood Rev; 1997 Sep; 11(3):129-45. PubMed ID: 9370044
[TBL] [Abstract][Full Text] [Related]
6. Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified.
Wang SA; Tam W; Tsai AG; Arber DA; Hasserjian RP; Geyer JT; George TI; Czuchlewski DR; Foucar K; Rogers HJ; Hsi ED; Bryan Rea B; Bagg A; Dal Cin P; Zhao C; Kelley TW; Verstovsek S; Bueso-Ramos C; Orazi A
Mod Pathol; 2016 Aug; 29(8):854-64. PubMed ID: 27174585
[TBL] [Abstract][Full Text] [Related]
7. Advances in diagnosis and treatment of eosinophilia.
Sheikh J; Weller PF
Curr Opin Hematol; 2009 Jan; 16(1):3-8. PubMed ID: 19057198
[TBL] [Abstract][Full Text] [Related]
8. Causes of hypereosinophilia in 100 consecutive patients.
Moller D; Tan J; Gauiran DTV; Medvedev N; Hudoba M; Carruthers MN; Dehghan N; van den Berghe J; Bruyère H; Chen LYC
Eur J Haematol; 2020 Sep; 105(3):292-301. PubMed ID: 32364630
[TBL] [Abstract][Full Text] [Related]
9. [Spectrum of hypereosinophilia syndrome based on 2 clinical case reports].
Nolte H; Helmchen U
Med Klin (Munich); 1998 Jul; 93(7):426-32. PubMed ID: 9711056
[TBL] [Abstract][Full Text] [Related]
10. Hypereosinophilic Syndrome.
Curtis C; Ogbogu P
Clin Rev Allergy Immunol; 2016 Apr; 50(2):240-51. PubMed ID: 26475367
[TBL] [Abstract][Full Text] [Related]
11. Practical approach to the patient with hypereosinophilia.
Roufosse F; Weller PF
J Allergy Clin Immunol; 2010 Jul; 126(1):39-44. PubMed ID: 20538328
[TBL] [Abstract][Full Text] [Related]
12. [Hypereosinophilia: what is important to the clinician?].
Bertrand E
Med Trop (Mars); 1998; 58(4 Suppl):512. PubMed ID: 10410377
[No Abstract] [Full Text] [Related]
13. [Diagnostic approach to hypereosinophilia].
Granel B; Serratrice J; Schleinitz N; Veit V; Swiader L; Disdier P; Harle JR; Dessein A; Weiller PJ
Med Trop (Mars); 1998; 58(4 Suppl):489-92. PubMed ID: 10410372
[TBL] [Abstract][Full Text] [Related]
14. Relationship between idiopathic hypereosinophilic syndrome, eosinophilic leukemia, and systemic mastocytosis.
Bain BJ
Am J Hematol; 2004 Sep; 77(1):82-5. PubMed ID: 15307112
[TBL] [Abstract][Full Text] [Related]
15. Eosinophilia and Hypereosinophilic Disorders - Update on Etiopathogeny, Classification and Clinical Approach.
Leru PM
Rom J Intern Med; 2015; 53(4):289-95. PubMed ID: 26939204
[TBL] [Abstract][Full Text] [Related]
16. [Hypereosinophilic syndrome and eosinophilic leukemia].
Robak T; Krykowski E
Acta Haematol Pol; 1995; 26(1):5-13. PubMed ID: 7747563
[No Abstract] [Full Text] [Related]
17. [Hypereosinophilic syndrome as paraneoplastic presentation in an adolescent].
Arias-Martínez I; Venancio-Hernández M
Rev Alerg Mex; 2013; 60(4):193-7. PubMed ID: 24912912
[TBL] [Abstract][Full Text] [Related]
18. [Investigation of chronic hypereosinophilia: new perspectives].
Prin L; Roumier AS
Therapie; 2001; 56(4):389-95. PubMed ID: 11677861
[TBL] [Abstract][Full Text] [Related]
19. Unexplained hypereosinophilia and the need for cytogenetic and molecular genetic analyses.
Smith KJ; Jacobson E; Hamza S; Skelton H
Arch Dermatol; 2004 May; 140(5):584-8. PubMed ID: 15148104
[TBL] [Abstract][Full Text] [Related]
20. Hypereosinophilia and metastatic anaplastic carcinoma of unknown primary.
Abali H; Altundag MK; Engin H; Altundag OO; Türker A; Uner A; Ruacan S
Med Oncol; 2001; 18(4):285-8. PubMed ID: 11918455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
